Andrew Cooper
Stock Analyst at Raymond James
(2.26)
# 1,393
Out of 4,479 analysts
106
Total ratings
44.86%
Success rate
-6.91%
Average return
Main Sectors:
18 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CDNA CareDx | Downgrades: Market Perform | n/a | $14.90 | - | 13 | May 13, 2024 | |
| NTRA Natera | Downgrades: Outperform | $68 → $85 | $110.70 | -23.22% | 5 | Feb 20, 2024 | |
| QDEL QuidelOrtho | Downgrades: Outperform | $100 → $76 | $31.36 | +142.35% | 12 | Feb 14, 2024 | |
| HOLX Hologic | Maintains: Outperform | $85 → $88 | $73.53 | +19.68% | 9 | Feb 2, 2024 | |
| RVTY Revvity | Maintains: Outperform | $106 → $127 | $102.01 | +24.50% | 4 | Feb 2, 2024 | |
| TMO Thermo Fisher | Maintains: Outperform | $515 → $605 | $533.93 | +13.31% | 4 | Feb 1, 2024 | |
| DHR Danaher | Maintains: Outperform | $240 → $270 | $240.41 | +12.31% | 5 | Jan 31, 2024 | |
| AVTR Avantor | Maintains: Outperform | $23 → $26 | $20.58 | +26.34% | 11 | Jan 26, 2024 | |
| GH Guardant Health | Upgrades: Outperform | $27 | $28.87 | -6.48% | 2 | Nov 13, 2023 | |
| CTKB Cytek Biosciences | Initiates: Market Perform | n/a | $5.60 | - | 1 | Jul 19, 2023 | |
| AZTA Azenta | Initiates: Market Perform | n/a | $51.53 | - | 1 | Jul 19, 2023 | |
| NEO NeoGenomics | Downgrades: Market Perform | n/a | $13.73 | - | 9 | May 16, 2023 | |
| MYGN Myriad Genetics | Maintains: Outperform | $25 → $27 | $24.76 | +9.05% | 3 | Mar 3, 2023 | |
| EXAS Exact Sciences | Downgrades: Market Perform | n/a | $43.17 | - | 7 | Jan 18, 2023 | |
| VCYT Veracyte | Downgrades: Market Perform | n/a | $21.26 | - | 8 | Jan 18, 2023 | |
| FLGT Fulgent Genetics | Initiates: Outperform | $45 | $19.98 | +125.23% | 1 | Nov 18, 2022 | |
| HAE Haemonetics | Maintains: Outperform | $88 → $100 | $83.06 | +20.39% | 6 | Nov 8, 2022 | |
| OSUR OraSure Technologies | Downgrades: Market Perform | n/a | $4.08 | - | 5 | Sep 22, 2021 |
CareDx
May 13, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $14.90
Upside: -
Natera
Feb 20, 2024
Downgrades: Outperform
Price Target: $68 → $85
Current: $110.70
Upside: -23.22%
QuidelOrtho
Feb 14, 2024
Downgrades: Outperform
Price Target: $100 → $76
Current: $31.36
Upside: +142.35%
Hologic
Feb 2, 2024
Maintains: Outperform
Price Target: $85 → $88
Current: $73.53
Upside: +19.68%
Revvity
Feb 2, 2024
Maintains: Outperform
Price Target: $106 → $127
Current: $102.01
Upside: +24.50%
Thermo Fisher
Feb 1, 2024
Maintains: Outperform
Price Target: $515 → $605
Current: $533.93
Upside: +13.31%
Danaher
Jan 31, 2024
Maintains: Outperform
Price Target: $240 → $270
Current: $240.41
Upside: +12.31%
Avantor
Jan 26, 2024
Maintains: Outperform
Price Target: $23 → $26
Current: $20.58
Upside: +26.34%
Guardant Health
Nov 13, 2023
Upgrades: Outperform
Price Target: $27
Current: $28.87
Upside: -6.48%
Cytek Biosciences
Jul 19, 2023
Initiates: Market Perform
Price Target: n/a
Current: $5.60
Upside: -
Azenta
Jul 19, 2023
Initiates: Market Perform
Price Target: n/a
Current: $51.53
Upside: -
NeoGenomics
May 16, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $13.73
Upside: -
Myriad Genetics
Mar 3, 2023
Maintains: Outperform
Price Target: $25 → $27
Current: $24.76
Upside: +9.05%
Exact Sciences
Jan 18, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $43.17
Upside: -
Veracyte
Jan 18, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $21.26
Upside: -
Fulgent Genetics
Nov 18, 2022
Initiates: Outperform
Price Target: $45
Current: $19.98
Upside: +125.23%
Haemonetics
Nov 8, 2022
Maintains: Outperform
Price Target: $88 → $100
Current: $83.06
Upside: +20.39%
OraSure Technologies
Sep 22, 2021
Downgrades: Market Perform
Price Target: n/a
Current: $4.08
Upside: -